Arbutus Biopharma Corporation ABUS Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
Based on trailing twelve months.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's free cash flow margin?
- Arbutus Biopharma Corporation (ABUS) reported free cash flow margin of -281.5% in Q4 2025.
- How has Arbutus Biopharma Corporation's free cash flow margin changed year-over-year?
- Arbutus Biopharma Corporation's free cash flow margin increased by 73.3% year-over-year, from -1,053.8% to -281.5%.
- What is the long-term trend for Arbutus Biopharma Corporation's free cash flow margin?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's free cash flow margin has grown at a -17.7% compound annual growth rate (CAGR), from -747.3% to -281.5%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.